Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2025
FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease
29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
Posted by Michael Wonder on 12 Jul 2021
SMC - July 2021 decisions
12 July 2021 - The SMC has today published advice accepting three new medicines. ...
Posted by Michael Wonder on 12 Jul 2021
CMS opens national coverage determination analysis on treatment for Alzheimer’s disease
12 July 2021 - Today, the Centers for Medicare & Medicaid Services is opening a National Coverage Determination analysis, a ...
Posted by Michael Wonder on 12 Jul 2021
FDA to announce new warning on J&J COVID vaccine related to a rare auto-immune disorder, report says
12 July 2021 - About 100 preliminary reports of Guillain-Barre syndrome have been detected after 12.8 million doses of the J&J ...
Posted by Michael Wonder on 12 Jul 2021
In a sweeping executive order, Biden endorses importing drugs from Canada and orders a bigger drug pricing plan by late August
9 July 2021 - President Biden on Friday will take aim at the pharmaceutical industry by ordering his administration to ...
Posted by Michael Wonder on 12 Jul 2021
Teplizumab awarded Innovation Passport in the United Kingdom for the delay of onset of clinical type 1 diabetes in at risk individuals
12 July 2021 - Designation is the first step in a new MHRA initiative to accelerate the development and access to ...
Posted by Michael Wonder on 12 Jul 2021
FDA approves daratumumab and hyaluronidase-fihj with pomalidomide and dexamethasone for multiple myeloma
12 July 2021 - On 9 July 2021, the FDA approved daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech) in combination ...
Posted by Michael Wonder on 12 Jul 2021
Minister for Health announces HSE approval to reimburse patisiran (Onpattro)
12 July 2021 - The Minister for Health, Stephen Donnelly TD is pleased to announce that the drug patisiran (Onpattro) ...
Posted by Michael Wonder on 12 Jul 2021
FDA’s expansive Alzheimer’s drug approval surprised even top agency officials
9 July 2021 - The FDA’s contentious decision to approve a new Alzheimer’s drug for every single patient with the ...
Posted by Michael Wonder on 12 Jul 2021
‘MSD Korea proposed unprecedented offer for Keytruda reimbursement’
12 July 2021 - MSD’s Keytruda (pembrolizumab), immunotherapy for lung cancer, is the company’s flagship item that sold $14.38 billion ...
Posted by Michael Wonder on 12 Jul 2021
Experts warn full FDA COVID-19 vaccine approval is no quick fix for hesitancy
12 July 2021 - The FDA issuing full approval for two COVID-19 vaccines might not be the game changer it’s ...
Posted by Michael Wonder on 12 Jul 2021
Leukaemia patients demand reimbursement for Novartis’ Kymriah
12 July 2021 - Korean leukaemia patients have urged the government to provide rapid reimbursement of Kymriah, the first CAR-T ...
Posted by Michael Wonder on 12 Jul 2021
Drug prices weigh on older Americans
9 July 2021 - Most Americans ages 50 and older rely on prescription drugs for their health, yet many worry ...
Posted by Michael Wonder on 12 Jul 2021
Wesfarmers lobs $687 million takeover of Australian Pharmaceutical Industries
12 July 2021 - Wesfarmers has lobbed a $687 million takeover of Priceline owner API. But don’t expect pharmacies to pop ...
Posted by Michael Wonder on 11 Jul 2021
What a waste! The National Academy of Medicine’s report on oversized vials of expensive drugs
9 July 2021 - In 2016, my colleagues and I tabulated $2 billion in excess spending across the US health care ...
Posted by Michael Wonder on 11 Jul 2021
The growing problem of out of pocket costs and affordability in employer sponsored insurance
9 July 2021 - While policy makers and health leaders have appropriately focused on addressing the COVID-19 pandemic, underlying racial and ...